NCT07281118 Intercostal Cryoanalgesia in Double Lung Transplant Recipients
| NCT ID | NCT07281118 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Post-operative Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 148 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2027-11-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 148 participants in total. It began in 2025-12-16 with a primary completion date of 2027-11-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.
Eligibility Criteria
Inclusion Criteria: * Adults ≥18 years of age * Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision Exclusion Criteria: * Multi-organ transplant recipients * Redo lung transplant recipients
Contact & Investigator
Abbas Ardehali, MD
PRINCIPAL INVESTIGATOR
University of California, Los Angeles
Frequently Asked Questions
Who can join the NCT07281118 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post-operative Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07281118 currently recruiting?
Yes, NCT07281118 is actively recruiting participants. Contact the research team at sstokes@mednet.ucla.edu for enrollment information.
Where is the NCT07281118 trial being conducted?
This trial is being conducted at Los Angeles, United States, San Francisco, United States, Waco, United States.
Who is sponsoring the NCT07281118 clinical trial?
NCT07281118 is sponsored by University of California, Los Angeles. The principal investigator is Abbas Ardehali, MD at University of California, Los Angeles. The trial plans to enroll 148 participants.